Pfizer Inc. posted higher-than-expected quarterly results and stood by its longer-term profit view, allaying investor concern over looming generic drug competition and lifting its shares 5%.
*For more on this story, read the full Reuters article.
Pfizer Inc. posted higher-than-expected quarterly results and stood by its longer-term profit view, allaying investor concern over looming generic drug competition and lifting its shares 5%.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99